Log in to save to my catalogue

Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study

Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04760089v1

Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study

About this item

Full title

Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study

Publisher

London, England: SAGE Publications

Journal title

Multiple sclerosis journal - experimental, translational and clinical, 2024-01, Vol.10 (1), p.20552173241233952-20552173241233952

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Objective
To assess the efficacy of dalfampridine in patients with neuromyelitis optica spectrum disorder.
Methods
We included 15 consecutive patients, who were started on a treatment of dalfampridine 10 mg twice daily for 2 weeks. Efficacy assessment was based on walking ability improvement using Timed-25-Foot Walk and 12-item Multiple Sc...

Alternative Titles

Full title

Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04760089v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04760089v1

Other Identifiers

ISSN

2055-2173

E-ISSN

2055-2173

DOI

10.1177/20552173241233952

How to access this item